Marketing Regulation

We provide legal advice to domestic and overseas pharmaceutical companies, medical device manufacturers, bio-venture companies, research insutitute such as universities and contract research organizations (CROs) and other various clients. We have extensive experience advising on licenses, filing and other requirements for the Marketing Authorization Holder (MAH) and the sellers of drugs and medical devices, and drafting and reviewing documents for such bisinesses.

Contact us

PublicationsArchives

2026.01.30
Legal Affairs for Chinese Life Sciences and Healthcare No. 27: A Cross-border Staged Manufacturing Model for Pharmaceuticals
2025.11.28
Legal Affairs for Chinese Life Sciences and Healthcare No. 26: Progress in Domestic Manufacturing Policies for Medical Devices
2025.09.25
Legal Affairs for Chinese Life Sciences and Healthcare No. 25: Update on the Amendments to China's Medical Device Laws and Regulations
2025.05.27
Legal Affairs for Chinese Life Sciences and Healthcare No. 24: Update on the Revisions to Chinese Pharmaceutical Regulations
2025.04.01
Direction of the Revision of the Pharmaceutical and Medical Device Act and Related Systems - Quality Assurance, Stable Supply, Support for Drug Discovery, Development of Pharmacy Functions, etc.
2025.03.24
Legal Affairs for Chinese Life Sciences and Healthcare No. 23: Updates on the Amendments of Pharmaceutical Laws and Regulations of China
2024.01.24
Legal Affairs for Chinese Life Sciences and Healthcare No. 21: Revision to the Administrative Regulation on Wholesale, Retail, etc., of Pharmaceutical Products (Establishment of the Regulation on Supervision and Administration of Business Management and Q
2023.11.28
Legal Affairs for Chinese Life Sciences and Healthcare No. 20: Notice on Enhancing the Supervision and Administration of Contract Manufacture of Drug Marketing Authorization Holders (No. 132 of 2023)
2023.08.24
Thematic-based: Legal Practice in the Healthcare Business
2022.07.04
China's Life Sciences and Healthcare-No.2 -The Good Vigilance Practice rule in China
2022.05.26
Legal Affairs for Chinese Life Sciences and Healthcare (Part 10) - Toward the Enforcement of the New Cosmetics GMP
2022.03.24
Legal Affairs for Chinese Life Sciences and Healthcare (Part 8) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the
2022.02.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 7) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 5) - Amendment to the Cosmetic Supervision and Administration Regulation for the First Time in 30 Years, and the Subsidiary Regulations on Administrative Measures for Cosmetic Registration, the
2022.01.21
Legal Affairs for Chinese Life Sciences and Healthcare (Part 6) - Trial Program for Cross-border E-commerce Retail Import of Drugs in Henan
2021.11.24
Legal Affairs for Chinese Life Sciences and Healthcare (Part 4) - Developments in Amendment of Regulations Concerning Wholesaling/Retailing of Pharmaceutical Products, Etc. (Measures on Supervision and Control of the Drug Business and Usage Quality (Draft
2021.10.28
Legal Affairs for Chinese Life Sciences and Healthcare (Part 3) -Approaching the implementation of China GVP (Good Pharmacovigilance Practice) (effective from December 1, 2021) (2)

MORE

SeminarsArchives

2026.10.23
【Hybrid Seminar】】Series of Seminars on Life Science Practices (5): Designing Contractual Terms for Medical Device M&A--Closing Conditions, Consideration Adjustments and Duty of Cooperation
2026.08.28
【Online Seminar】Series of Seminars on Life Science Practices (3): Basics of Quality Contracts Legal Affairs Personnel Should Know
2025.07.14
Overview of/Law Amendment Information concerning the Latest Medical Device Regulations in China, and Related Requirements 2025
2025.03.13
[Online Seminar] Overview of/Law Amendment Updates concerning the Latest Medical Device Regulations in China 2025
2024.10.25
【Online Seminar】 Series of Seminars on M&A in Various Business Fields (4): Pharmacies
2024.08.21
【Online Seminar】 Series of Seminars on M&A in Various Business Fields (2): Medical Devices
2024.05.23
[Online Seminar] Overview of/Law Amendment Updates concerning the Latest Medical Device Regulations in China 2024
2023.06.16
[Online Seminar] Latest Medical Device Regulations in China 2023
2022.10.04
【Onilne Seminar】Life Science Practice Seminar No.8: Legal Practices for Settlement of Pharmaceutical Patent Disputes
2022.09.09
【Online seminar】Catch up on the Latest Practices in 30 Minutes! Concept and Practical Points to Note Regarding Corporate Governance Relating to Tax Affairs; Key Points of the Act on Promotion of Economic Security and Practical Actions Therefor; and Produc
2021.07.09
【Onilne Seminar】Life Science Practice Seminar No.2: Legal Practice for Collection of Pharmaceutical Products, etc.
2021.04.16
【Onilne Seminar】Life Science Practice Seminar No.1: System Operation and Trends Regarding Regenerative Medicine Products as Observed in Recent PMDA Consultation/Approval Cases

MORE

ページTOPへ